D. RAS–MAPK pathway dysregulation, commonly involving PTPN11
Why this is correct
Noonan syndrome is a RASopathy caused by pathogenic variants in genes of the RAS–MAPK signaling pathway, often PTPN11. Typical features include short stature, distinctive facial and chest characteristics, variable developmental or coagulation issues, and congenital cardiac lesions—especially dysplastic pulmonary valve stenosis or hypertrophic cardiomyopathy. The syndrome occurs in both sexes and is often autosomal dominant, differing from Turner syndrome.
Why each option is correct or incorrect
DMD defects cause Duchenne or Becker muscular dystrophy, not the Noonan syndrome constellation.
CFTR mutations cause cystic fibrosis and do not characteristically produce dysplastic pulmonary stenosis with Noonan facies.
Trisomy 21 is associated with AV septal defects and other findings, but the described syndrome and pathway do not match.
Correct: Noonan syndrome is a RAS–MAPK signaling disorder frequently involving PTPN11.
High-yield notes
- Noonan syndrome is a RASopathy.
- Pulmonary valve stenosis is a classic Noonan cardiac lesion.
- PTPN11 encodes SHP2 phosphatase within RAS–MAPK signaling.
Webbed neck occurs in both Noonan and Turner; pulmonary valve stenosis strongly favors Noonan in this vignette.
Do not assume a webbed neck automatically indicates a 45,X karyotype, especially in a male child.